Rachit Agrawal/LinkedIn
Sep 20, 2025, 07:27
Rachit Agrawal Highlights Clinical Breakthrough in Sitosterolemia and Hemolytic Anemia
Rachit Agrawal, Clinical Hematologist, Hemato-oncologist, and BMT physician at Fortis Memorial Research Institute, Gurugram, shared a post on LinkedIn:
“Excited to announce the publication of our case series on sitosterolemia in IJHBT. Sitosterolemia is a crucial consideration for patients presenting with unexplained hemolytic anemia. We observed a remarkable clinical improvement with simple interventions.”
Title: Sitosterolemia: Unveiling an Underdiagnosed Case Series of Haemolytic Anaemia
Authors: Mehak Trehan, Rachit Agrawal, Amiya Ranjan Nayak, Rishi Dhawan, Jasmita Dass, Ganesh Kumar, Pradeep Kumar, Richa Chauhan, Tulika Seth, Manoranjan Mahapatra, Mukul Aggarwal
Read full article here.
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery